Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation

E-ISSN： 1875-533x|18|35|5430-5447

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.35, 2011-12, pp. : 5430-5447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patents targeting γ-secretase inhibition and modulation for the treatment of Alzheimer's disease: 2004 – 2008

By Garofalo Albert W

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 693-703

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève Marijke Fleur Sernee Masters Colin L.

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

#947;-Secretase: Structure, Function, and Modulation for Alzheimers Disease

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. : 2-8

Bentham Science Publishers

Access to resources Recommend Favorite

Disease-Modifying Approach to the Treatment of Alzheimer's Disease: From α-Secretase Activators to γ-Secretase Inhibitors and Modulators

By Panza Francesco

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 537-555

Adis International

Access to resources Recommend Favorite

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

By Pettersson Martin Stepan Antonia F Kauffman Gregory W Johnson Douglas S

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1349-1366

Informa Healthcare

Access to resources Recommend Favorite